Bright Health Group, Inc. EBITDA
| Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|
| EBITDA | ($61.6M) | ($124.2M) | ($249.3M) | ($1,161.4M) | ($425.3M) | ($1,145.5M) |
Bright Health Group, Inc. (BHG) EBITDA comparison analysis
General
LTM EBITDA
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
BHG key stats
| Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|
% growth | 130.6 0.0% | 280.7 114.9% | 1,207.3 330.2% | 4,029.4 233.7% | 2,412.0 (40.1%) | 1,160.8 (51.9%) |
| Cost of Goods Sold (COGS) | 96.4 | 224.4 | 1,047.3 | 3,953.7 | 2,206.2 | 1,283.7 |
% margin | 34.2 26.2% | 56.3 20.1% | 160.0 13.3% | 75.7 1.9% | 205.8 8.5% | (122.9) (10.6%) |
| Operating Expenses | 96.9 | 181.6 | 417.6 | 1,273.9 | 682.5 | 1,737.8 |
| Research & Development Expenses (R&D) | 2.5 | 7.2 | 19.4 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 81.2 | 153.9 | 308.7 | 914.1 | 584.2 | 0.0 |
% margin | (62.6) (48.0%) | (125.3) (44.7%) | (257.6) (21.3%) | (1,198.2) (29.7%) | (476.7) (19.8%) | (627.7) (54.1%) |
| Interest Income | 0.0 | 0.0 | 0.0 | 7.2 | 12.8 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 8.0 | 12.8 | 38.2 |
| Pre-tax Income | (62.6) | (125.3) | (257.6) | (1,204.9) | (634.3) | (629.2) |
% effective tax rate | 3.5 (5.6%) | 8.4 (6.7%) | (9.2) 3.6% | (26.5) 2.2% | 3.7 (0.6%) | (1.4) 0.2% |
% margin | (62.6) (48.0%) | (133.7) (47.6%) | (248.4) (20.6%) | (1,178.4) (29.2%) | (638.0) (26.4%) | (1,200.6) (103.4%) |
| EPS | (37.97) | (79.52) | (145.94) | (240.33) | (81.08) | (150.94) |
| Diluted EPS | (37.97) | (79.52) | (145.94) | (240.33) | (81.08) | (150.94) |
% margin | (61.6) (47.2%) | (124.2) (44.3%) | (249.3) (20.7%) | (1,161.4) (28.8%) | (425.3) (17.6%) | (1,145.5) (98.7%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Bright Health Group, Inc.'s EBITDA?
As of today, Bright Health Group, Inc.'s last 12-month EBITDA is ($366.0M), based on the financial report for Dec 31, 2023 (Q4’2023).
2) What is Bright Health Group, Inc.'s EBITDA growth rate?
Over the last year, Bright Health Group, Inc.'s EBITDA growth was (45.7%). The average annual EBITDA growth rates for Bright Health Group, Inc. have been 126.1% over the past three years, 124.0% over the past five years.
3) Is Bright Health Group, Inc.'s EBITDA growth rate Good?
Over the last year, Bright Health Group, Inc.'s EBITDA growth was (45.7%), which is lower than industry growth of (0.2%). It indicates that Bright Health Group, Inc.'s EBITDA growth is Bad.